Literature DB >> 28721696

Usefulness of fragmented QRS in hypertensive patients in the absence of left ventricular hypertrophy.

Mehmet Eyuboglu1, Yavuz Karabag2, Suleyman Karakoyun2, Omer Senarslan3, Zulkif Tanriverdi4, Bahri Akdeniz5.   

Abstract

In the absence of left ventricular hypertrophy, importance of fragmented QRS complex (fQRS) in individuals with hypertension is unknown. The authors aimed to evaluate the relationship between blood pressure levels and fQRS in the absence of left ventricular hypertrophy. A total of 548 never-treated patients who underwent 24-hour ambulatory blood pressure monitoring were enrolled. The frequency of fQRS was significantly higher in patients with hypertension than normotension (36.4% vs 17.6%, P<.05). Multivariate logistic regression analysis revealed that systolic blood pressure is significantly associated with presence of fQRS on electrocardiography (odds ratio, 0.931; 95% CI, 0.910-0.9521 [P<.001]) even after adjusting for other confounding factors. Receiver operating characteristic analysis revealed a cutoff value of 147.65 mm Hg for systolic blood pressure to predict presence of fQRS (sensitivity: 51%, specificity: 99%, area under the curve=0.764; 95% CI, 0.717-0.811 [P<.001]). fQRS may be a sign of increased blood pressure and may predict higher fibrotic burden in patients with hypertension. ©2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  fibrosis; fragmented QRS; hypertension

Mesh:

Year:  2017        PMID: 28721696      PMCID: PMC8030950          DOI: 10.1111/jch.13051

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  17 in total

1.  Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease.

Authors:  Mithilesh K Das; Bilal Khan; Sony Jacob; Awaneesh Kumar; Jo Mahenthiran
Journal:  Circulation       Date:  2006-05-22       Impact factor: 29.690

2.  Fragmented QRS on a 12-lead ECG: a predictor of mortality and cardiac events in patients with coronary artery disease.

Authors:  Mithilesh Kumar Das; Chandan Saha; Hicham El Masry; Jonathan Peng; Gopi Dandamudi; Jo Mahenthiran; Paul McHenry; Douglas P Zipes
Journal:  Heart Rhythm       Date:  2007-08-01       Impact factor: 6.343

3.  Significance of fragmented QRS complexes for identifying left ventricular hypertrophy in patients with hypertension.

Authors:  Baowei Zhang; Ya Zhen; Dongli Shen; Guohui Zhang
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-09-18       Impact factor: 1.468

Review 4.  QRS fragmentation: diagnostic and prognostic significance.

Authors:  Grzegorz Pietrasik; Wojciech Zaręba
Journal:  Cardiol J       Date:  2012       Impact factor: 2.737

5.  Fragmented QRS on twelve-lead electrocardiogram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy.

Authors:  Mithilesh Kumar Das; Waddah Maskoun; Changyu Shen; Mark A Michael; Hussam Suradi; Mona Desai; Roopa Subbarao; Deepak Bhakta
Journal:  Heart Rhythm       Date:  2009-10-02       Impact factor: 6.343

6.  Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans.

Authors:  M A Rossi
Journal:  J Hypertens       Date:  1998-07       Impact factor: 4.844

7.  Usefulness of Fragmented QRS Complex to Predict Arrhythmic Events and Cardiovascular Mortality in Patients With Noncompaction Cardiomyopathy.

Authors:  Mehmet Serkan Cetin; Elif Hande Ozcan Cetin; Ugur Canpolat; Serkan Cay; Serkan Topaloglu; Ahmet Temizhan; Sinan Aydogdu
Journal:  Am J Cardiol       Date:  2016-02-18       Impact factor: 2.778

Review 8.  Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension: an updated review.

Authors:  Cesare Cuspidi; Marta Rescaldani; Carla Sala; Francesca Negri; Guido Grassi; Giuseppe Mancia
Journal:  J Hypertens       Date:  2012-11       Impact factor: 4.844

9.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

Review 10.  Fragmented ECG as a risk marker in cardiovascular diseases.

Authors:  Rahul Jain; Robin Singh; Sundermurthy Yamini; Mithilesh K Das
Journal:  Curr Cardiol Rev       Date:  2014-08
View more
  6 in total

1.  Fragmented QRS as a Marker of Myocardial Fibrosis in Hypertension: a Systematic Review.

Authors:  Mehmet Eyuboglu
Journal:  Curr Hypertens Rep       Date:  2019-08-26       Impact factor: 5.369

2.  Association Between Non-Dipping and Fragmented QRS Complexes in Prehypertensive Patients.

Authors:  Mehmet Eyuboglu; Bahri Akdeniz
Journal:  Arq Bras Cardiol       Date:  2018-12-17       Impact factor: 2.000

3.  Patients with Dipper and Nondipper High-Normal Blood Pressure Were Associated with Left Ventricular Mass.

Authors:  Fan-Kai Xiao; Ping Li; Zhan-Ying Han; Li Jing; Shaohua Hua; Luo-Sha Zhao
Journal:  Int J Hypertens       Date:  2021-12-21       Impact factor: 2.420

4.  Relationship Between Fragmented QRS Complex and Long-Term Cardiovascular Outcome in Patients with Essential Hypertension.

Authors:  Mehmet Altunova; Hamdi Püşüroğlu; Muammer Karakayalı; Ahmet Anıl Şahin; Ali Rıza Demir; Emre Yılmaz; Ahmet Yaşar Çizgici; Mehmet Ertürk
Journal:  Anatol J Cardiol       Date:  2022-06       Impact factor: 1.475

5.  Usefulness of fragmented QRS in hypertensive patients in the absence of left ventricular hypertrophy.

Authors:  Mehmet Eyuboglu; Yavuz Karabag; Suleyman Karakoyun; Omer Senarslan; Zulkif Tanriverdi; Bahri Akdeniz
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-07-18       Impact factor: 3.738

6.  A high-performance 8 nV/√Hz 8-channel wearable and wireless system for real-time monitoring of bioelectrical signals.

Authors:  Konstantinos Petkos; Simos Koutsoftidis; Thomas Guiho; Patrick Degenaar; Andrew Jackson; Stephen E Greenwald; Peter Brown; Timothy Denison; Emmanuel M Drakakis
Journal:  J Neuroeng Rehabil       Date:  2019-12-10       Impact factor: 4.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.